Ryan L Crass

13PUBLICATIONS
9CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMedical biochemistry - inorganic elements and compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 05, 2024
Pharmacokinetic/pharmacodynamic analysis of geographic atrophy lesion area in patients receiving pegcetacoplan treatment or sham.

Ryan L Crass, Komal Prem, Francois Gaudreault

|May 27, 2023
Population pharmacokinetic and pharmacokinetic-pharmacodynamic modeling of bempedoic acid and low-density lipoprotein cholesterol in healthy subjects and patients with dyslipidemia.

Satyawan B Jadhav, Benny M Amore, Howard Bockbrader

|Jun 09, 2022
Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin.

Madeline A Lipp, Ryan L Crass, Linda J Fitzgerald

|Dec 11, 2021
Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19.

Elizabeth Leung, Ryan L Crass, Sarah C J Jorgensen

|Nov 27, 2021
Translation of Pharmacodynamic Biomarkers of Antibiotic Efficacy in Specific Populations to Optimize Doses.

Manjunath P Pai, Ryan L Crass

|Jul 12, 2021
Pharmacokinetics of Polymyxin B in Hospitalized Adults with Cystic Fibrosis.

Ryan L Crass, Tamara Al Naimi, Bo Wen

Pageof 3

Frequent Collaborators

9 joint publications

Manjunath P Pai

1 joint publications

Elizabeth Leung

1 joint publications

Nathaniel J Rhodes

1 joint publications

Shijing Jia